Cargando…
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with limited treatment options. Despite decades of therapeutic development, only two modestly efficacious disease-modifying drugs—riluzole and edaravone—are available to ALS patients. Biomarkers that can facilitate ALS diagnos...
Autores principales: | Chew, Sheena, Atassi, Nazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405430/ https://www.ncbi.nlm.nih.gov/pubmed/30881332 http://dx.doi.org/10.3389/fneur.2019.00135 |
Ejemplares similares
-
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019) -
Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019) -
Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019) -
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
por: Proudfoot, Malcolm, et al.
Publicado: (2019) -
Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)